http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AT-276628-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb75b0b19820e3833ebdcb31603b242b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-645
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N63-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-145
filingDate 1968-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1969-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1969-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AT-276628-B
titleOfInvention Process for the preparation of the new anti-inflammatory substance Zygosporin A.
priorityDate 1968-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425724917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414862178
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457673780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71308181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5458428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428401458
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524931

Total number of triples: 30.